Skip to Content

    News

    News

    The Alzheimer's Association is dedicated to promoting awareness of the latest Alzheimer's research, resources and news. Any news release posted here reflects the knowledge, statistics and position of the Alzheimer's Association at that time. Browse and share the articles below, or sign up for our e-newsletter to stay informed on the global fight against Alzheimer's.

    Featured News Items

    Press releases & statements

    Alzheimer’s Association and Alzheimer’s Impact Movement Statement on Senate’s Proposed Medicaid Cuts

    While it would avoid the most harmful alternatives for people living with dementia, the Senate's proposed Medicaid cuts threaten a lifeline for this community. 
    June 17, 2025
    Press releases & statements

    Alzheimer's Association Part the Cloud Grants $5 Million to Develop Innovative Gene Targeting Treatments

    This unique and unprecedented funding program is focused on gene targeting: potential therapies that change the expression of a gene at some level.
    June 13, 2025
    Press releases & statements

    New Analysis Finds Dementia Caregivers More Likely to Report Modifiable Risk Factors That Increase Their Own Risk for Dementia

    The first-of-its-kind analysis found that dementia caregivers are significantly more likely than the general population to experience conditions such as obesity, diabetes, poor sleep, smoking and hypertension.
     
    June 12, 2025
    Press releases & statements

    NIH Director Affirms to Congress His Commitment to Advancing Progress on Alzheimer’s

    National Institutes of Health (NIH) Director Dr. Jay Bhattacharya affirmed his commitment to advancing progress in the fight against Alzheimer’s disease and other dementia in a Senate budget hearing.
    June 10, 2025
    Press releases & statements

    Alzheimer’s Association Honors Senators Cassidy and Cortez Masto at 2025 AIM Advocacy Forum

    Sens. Bill Cassidy and Catherine Cortez Masto receive the 2025 AIM Humanitarian Award for their work to advance bipartisan policies for the Alzheimer’s and dementia community.
    June 9, 2025
    Press releases & statements

    Alzheimer’s Association Statement on Topline Results of the BROADWAY Clinical Trial Sub-study

    NewAmsterdam Pharma Company announced positive results from an Alzheimer’s disease blood biomarkers sub-study of the 52-week Phase 3 BROADWAY clinical trial of its LDL cholesterol lowering drug, obicetrapib.
    June 9, 2025

    Press Resources

    Media resources are available, including fact sheets and multimedia assets.

    View Press Resources

    Speaker Bios

    Maria C. Carrillo, Ph.D.

    Chief Science Officer and Medical Affairs Lead, Alzheimer’s Association

    See Bio

    Robert Egge

    Chief Public Policy Officer, Alzheimer’s Association and President, Alzheimer's Impact Movement

    See Bio

    Heather M. Snyder, Ph.D.

    Senior Vice President, Medical & Scientific Operations

    See Bio